Benzothia(oxa)diazol derivatives and their use as endothelin-receptor antagonists
US6197800A · kind A · utility
1Cited by
1References
21Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 27, 2000 |
| Grant date | Mar 6, 2001 |
| Priority date | — |
| Expiry date | Mar 27, 2020 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D417/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Novel compounds of the formula I ##STR1## in which PA1 R is ##STR2## PA1 X is O or S, and PA1 R.sup.1, R.sup.2, R.sup.3, R.sup.4, R.sup.5 and R.sup.6 have the meaning indicated in patent claim 1, PA1 or a tautomeric ring-closed form, and the (E) isomers and their salts PA1 exhibit endothelin receptor-antagonistic properties.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.